Old	New	Differences
1	1
2	2
3	3	Req. No. 10120 Page 1 1
4	4	2
5	5	3
6	6	4
7	7	5
8	8	6
9	9	7
10	10	8
11	11	9
12	12	10
13	13	11
14	14	12
15	15	13
16	16	14
17	17	15
18	18	16
19	19	17
20	20	18
21	21	19
22	22	20
23	23	21
24	24	22
25	25	23
26	26	24
27	27
28	28	STATE OF OKLAHOMA
29	29
30	30	2nd Session of the 58th Legislature (2022)
31	31
32	32	HOUSE BILL 4193 By: Echols
33	33
34	34
35	35
36	36
37	37
38	38	AS INTRODUCED
39	39
40	40	An Act relating to public health and safety; amending
41	41	63 O.S. 2021, Section 2 -303, which relates to the
42	42	Uniform Controlled Dangerous Substances Act;
43	43	increasing certain registration fee; and provi ding an
44	44	effective date.
45	45
46	46
47	47
48	48
49	49
50	50	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
51	51	SECTION 1. AMENDATORY 63 O.S. 2021, Section 2 -303, is
52	52	amended to read as follows:
53	53	Section 2-303. A. The Director of the Oklahoma State Bureau of
54	54	Narcotics and Dangerous Drugs Control shall register an applicant to
55	55	own a medical facility as described in subsection C of Section 2 -302
56	56	of this title, or to manufacture, distribu te, dispense, prescribe,
57	57	administer or use for scientific purposes controlled dangerous
58	58	substances included in Schedules I through V of Section 2 -101 et
59	59	seq. of this title unless the Director determines that the issuance
60	60	of such registration is inconsisten t with the public interest. In
61	61	determining the public interest, the following factors shall be
62	62	considered:
63	63
64	64	Req. No. 10120 Page 2 1
65	65	2
66	66	3
67	67	4
68	68	5
69	69	6
70	70	7
71	71	8
72	72	9
73	73	10
74	74	11
75	75	12
76	76	13
77	77	14
78	78	15
79	79	16
80	80	17
81	81	18
82	82	19
83	83	20
84	84	21
85	85	22
86	86	23
87	87	24
88	88
89	89	1. Maintenance of effective controls against diversion of
90	90	particular controlled dangerous substances and any Schedule I or II
91	91	substance compounded therefrom into other than legitimate medical,
92	92	scientific or industrial channels, including examination of the
93	93	fitness of his or her employees or agents to handle dangerous
94	94	substances;
95	95	2. Compliance with applicable state and local law;
96	96	3. Has been found g uilty of, entered a plea of guilty or nolo
97	97	contendere to a charge under the Uniform Controlled Dangerous
98	98	Substances Act or any other state or federal law relating to any
99	99	substance defined herein as a controlled dangerous substance or any
100	100	felony under the laws of any state or the United States;
101	101	4. Furnishing by the applicant false or fraudulent material
102	102	information in any application filed under Section 2 -101 et seq. of
103	103	this title;
104	104	5. Past experience in the manufacture, distribution,
105	105	dispensing, prescribin g, administering or use for scientific
106	106	purposes of controlled dangerous substances, and the existence in
107	107	the establishment of effective controls against diversion;
108	108	6. Denial, suspension or revocation of the applicant 's federal
109	109	registration to manufacture, distribute or dispense controlled
110	110	dangerous substances as authorized by federal law; and
111	111	7. Such other factors as may be relevant to and consistent with
112	112	the public health and safety.
113	113
114	114	Req. No. 10120 Page 3 1
115	115	2
116	116	3
117	117	4
118	118	5
119	119	6
120	120	7
121	121	8
122	122	9
123	123	10
124	124	11
125	125	12
126	126	13
127	127	14
128	128	15
129	129	16
130	130	17
131	131	18
132	132	19
133	133	20
134	134	21
135	135	22
136	136	23
137	137	24
138	138
139	139	Nothing herein shall be deemed to require individual licensed
140	140	pharmacists to register under the provisions of the Uniform
141	141	Controlled Dangerous Substances Act.
142	142	B. Registration granted under subsection A of this section
143	143	shall not entitle a registrant to manufacture, distribute, dispense,
144	144	prescribe, administer or use for scient ific purposes controlled
145	145	dangerous substances in Schedule I or II other than those specified
146	146	in the registration.
147	147	C. Practitioners shall be registered to dispense, prescribe,
148	148	administer or use for scientific purposes substances in Schedules II
149	149	through V if they are authorized to carry on their respective
150	150	activities under the laws of this state. A registration application
151	151	by a practitioner who wishes to conduct research with Schedule I
152	152	substances shall be accompanied by evidence of the applicant 's
153	153	federal registration to conduct such activity and shall be referred
154	154	to the Medical Research Commission for advice. The Medical Research
155	155	Commission shall promptly advise the Director concerning the
156	156	qualifications of each practitioner requesting such registration.
157	157	Registration for the purpose of bona fide research or of use for
158	158	scientific purposes with Schedule I substances by a practitioner
159	159	deemed qualified by the Medical Research Commission may be denied
160	160	only on a ground specified in subsection A of Section 2 -304 of this
161	161	title or if there are reasonable grounds to believe that the
162	162	applicant will abuse or unlawfully transfer such substances or fail
163	163
164	164	Req. No. 10120 Page 4 1
165	165	2
166	166	3
167	167	4
168	168	5
169	169	6
170	170	7
171	171	8
172	172	9
173	173	10
174	174	11
175	175	12
176	176	13
177	177	14
178	178	15
179	179	16
180	180	17
181	181	18
182	182	19
183	183	20
184	184	21
185	185	22
186	186	23
187	187	24
188	188
189	189	to safeguard adequately such applicant 's supply of such substances
190	190	against diversion from legitimate medical or scient ific use.
191	191	D. 1. The Director shall initially permit persons to register
192	192	who own or operate any establishment engaged in the manufacture,
193	193	distribution, dispensing, prescribing, administering or use for
194	194	scientific purposes of any controlled dangerous subst ances prior to
195	195	June 4, 1991, and who are registered or licensed by the state. Fees
196	196	for registration under this section shall be as follows:
197	197	Practitioners and mid -level
198	198	practitioners $140.00 per year
199	199	of registration
200	200	Home Care Agencies, Hospices &
201	201	Home Care Services $140.00 annually
202	202	Medical Facility Owners $300.00 annually
203	203	Distributors $300.00 annually
204	204	Manufacturers $500.00
205	205	$2,500.00 annually
206	206	Manufacturer, Wholesaler, or
207	207	Distributor of drug products
208	208	containing pseudoephedrine
209	209	or phenylpropanolamine $300.00 annually
210	210	2. A registrant shall be required to pay double the amount of
211	211	the above-listed fee for any renewal of registration received more
212	212	than thirty (30) days late.
213	213
214	214	Req. No. 10120 Page 5 1
215	215	2
216	216	3
217	217	4
218	218	5
219	219	6
220	220	7
221	221	8
222	222	9
223	223	10
224	224	11
225	225	12
226	226	13
227	227	14
228	228	15
229	229	16
230	230	17
231	231	18
232	232	19
233	233	20
234	234	21
235	235	22
236	236	23
237	237	24
238	238
239	239	3. A Ten Dollar ($10.00) fee shall be charged for a duplicate
240	240	registration certificate.
241	241	E. Compliance by manufacturers and distributors with the
242	242	provisions of the Federal Controlled Substances Act, 21 U.S.C.,
243	243	Section 801 et seq., respecting registration, excluding fees, shall
244	244	be deemed sufficient to qualify for registration under this act.
245	245	SECTION 2. This act shall become effecti ve November 1, 2022.
246	246
247	247	58-2-10120 GRS 12/21/21

Oklahoma 2022 Regular Session

Oklahoma House Bill HB4193 Compare Versions